Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Dec;18(12):3426-34.
doi: 10.1158/1055-9965.EPI-09-0956.

Utility and relationships of biomarkers of smoking in African-American light smokers

Affiliations
Randomized Controlled Trial

Utility and relationships of biomarkers of smoking in African-American light smokers

Man Ki Ho et al. Cancer Epidemiol Biomarkers Prev. 2009 Dec.

Abstract

Although expired carbon monoxide (CO) and plasma cotinine (COT) have been validated as biomarkers of self-reported cigarettes per day (CPD) in heavy smoking Caucasians, their utility in light smokers is unknown. Further, variability in CYP2A6, the enzyme that mediates formation of COT from nicotine and its metabolism to trans-3'-hydroxycotinine (3HC), may limit the usefulness of COT. We assessed whether CO and COT are correlated with CPD in African-American light smokers (< or =10 CPD, n = 700), a population with known reduced CYP2A6 activity and slow COT metabolism. We also examined whether gender, age, body mass index, smoking mentholated cigarettes, or rate of CYP2A6 activity, by genotype and phenotype measures (3HC/COT), influence these relationships. At baseline, many participants (42%) exhaled CO of < or =10 ppm, the traditional cutoff for smoking, whereas few (3.1%) had COT below the cutoff of < or =14 ng/mL; thus, COT seems to be a better biomarker of smoking status in this population. CPD was weakly correlated with CO and COT (r = 0.32-0.39, P < 0.001), and those reporting fewer CPD had higher CO/cigarette and COT/cigarette, although the correlations coefficients between these variables were also weak (r = -0.33 and -0.08, P < 0.05). The correlation between CPD and CO was not greatly increased when analyzed by CYP2A6 activity, smoking mentholated cigarettes, or age, although it appeared stronger in females (r = 0.38 versus 0.21, P < 0.05) and obese individuals (r = 0.38 versus 0.24, P < 0.05). Together, these results suggest that CO and COT are weakly associated with self-reported cigarette consumption in African-American light smokers, and that these relationships are not substantially improved when variables previously reported to influence these biomarkers are considered.

PubMed Disclaimer

Figures

Fig 1
Fig 1
(A – C): Histogram of self-reported CPD and the biomarkers expired CO and plasma COT for study participants (n = 700). Cutoff values of expired CO at ≤ 10 ppm and plasma COT levels of ≤ 14 ng/ml have been traditionally used to differentiate smokers from non-smokers. Correlations are weak but significant between expired CO with CPD (D), plasma COT with CPD (E), and plasma COT with CO (F). Correlations are also significant between CO/cigarette with CPD (G) and COT/cigarette with CPD (H). Each point represents an individual. r = Pearson's correlation coefficient. Analyses were performed on log-transformed variables (CPD, expired CO, plasma COT) although raw data is plotted.
Fig 2
Fig 2
Relationship between CYP2A6 activity, CPD, expired CO, and plasma COT. Self-reported CPD and expired CO did not differ by CYP2A6 genotype (A, B) or 3HC/COT quartiles (D, E), while CYP2A6 slow metabolizers had significantly higher plasma COT levels compared to normal metabolizers (* p < 0.01, C) and those in the slowest 3HC/COT quartile had significantly higher plasma COT levels compared to those in the fastest quartile (#, p < 0.001, F). NM = normal metabolizers, IM = intermediate metabolizers, SM = slow metabolizers. Analyses were performed on log-transformed variables (CPD, expired CO, plasma COT) although raw data is plotted.

References

    1. Benowitz NL, Peyton J, III, Ahijevych K, et al. Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research. 2002;4:149–159. - PubMed
    1. Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, Vesey C, Saloojee Y. Comparison of tests used to distinguish smokers from nonsmokers. American Journal of Public Health. 1987;77:1435–1438. - PMC - PubMed
    1. Hukkanen J, Jacob P, III, Benowitz NL. Metabolism and Disposition Kinetics of Nicotine. Pharmacol Rev. 2005;57:79–115. - PubMed
    1. Scherer G. Carboxyhemoglobin and thiocyanate as biomarkers of exposure to carbon monoxide and hydrogen cyanide in tobacco smoke. Experimental and Toxicologic Pathology. 2006;58:101. - PubMed
    1. Perez-Stable EJ, Benowitz NL, Marin G. Is serum cotinine a better measure of cigarette smoking than self-report? Preventive Medicine. 1995;24:171–179. - PubMed

Publication types

MeSH terms